UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy

UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy

Source: 
Yahoo/Reuters
snippet: 

The battle of the weight loss drugs continues, as Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro.

According to online pharmacies, that's over Novo Nordisk's Wegovy.